Skip to main content
Top
Published in:

Open Access 01-12-2024 | Research

Navigating shared decision-making after the Life-Sustaining Treatment Decision Act: a qualitative study of in-depth interviews with terminal cancer patients, families, and healthcare professionals

Authors: Soo-Young Yu, Yu-eun Lee, Sung Joon Shin, Go-un Woo, Dalyong Kim, Jung Hye Kwon, Do Yeun Kim, Eunyoung Eunice Suh

Published in: Supportive Care in Cancer | Issue 12/2024

Login to get access

Abstract

Purpose

End-of-life decision-making, particularly relating to withholding life-sustaining treatment (LST), is a complex and emotionally charged process involving healthcare professionals, patients, and caregivers.

Methods

This qualitative study explored the decision-making process in South Korea, where cultural norms and ethical considerations influence the dynamics of shared decision-making (SDM). In-depth interviews were conducted with healthcare professionals, patients, and caregivers using a grounded theory approach to elucidate the themes and processes underlying SDM for LST. This study used the “6C” framework, which could reflect the intricacies of the SDM process.

Results

The results suggest that healthcare professionals face emotional challenges and an ethical dilemma in disclosing prognoses and discussing LST withholding, often deferring such discussions until the condition of patients worsens. Cultural factors, such as collectivist values and societal taboos surrounding death, influence decision-making dynamics, highlighting the need for tailored interventions and cultural competence in healthcare settings.

Conclusion

The proposed “6C” framework provides insights into addressing current challenges in SDM and emphasizes the importance of cultural norms and ethical obligations in end-of-life decision-making. Further research is warranted to examine the SDM process in diverse cultural contexts and develop interventions to enhance patient and family involvement in the decision-making process for LST.
Literature
1.
go back to reference Elwyn G et al (2005) The OPTION scale: measuring the extent that clinicians involve patients in decision-making tasks. Heal Expect 8:34–42CrossRef Elwyn G et al (2005) The OPTION scale: measuring the extent that clinicians involve patients in decision-making tasks. Heal Expect 8:34–42CrossRef
2.
go back to reference Edwards A, Elwyn G (2006) Inside the black box of shared decision making: distinguishing between the process of involvement and who makes the decision. Heal Expect 9:307–320CrossRef Edwards A, Elwyn G (2006) Inside the black box of shared decision making: distinguishing between the process of involvement and who makes the decision. Heal Expect 9:307–320CrossRef
3.
go back to reference Kim DY et al (2007) Do-not-resuscitate orders for terminal patients with cancer in teaching hospitals of Korea. J Palliat Med 10:1153–1158CrossRefPubMed Kim DY et al (2007) Do-not-resuscitate orders for terminal patients with cancer in teaching hospitals of Korea. J Palliat Med 10:1153–1158CrossRefPubMed
4.
go back to reference Oh DY et al (2006) CPR or DNR? End-of-life decision in Korean cancer patients: a single center’s experience. Support Care Cancer 14:103–108CrossRefPubMed Oh DY et al (2006) CPR or DNR? End-of-life decision in Korean cancer patients: a single center’s experience. Support Care Cancer 14:103–108CrossRefPubMed
5.
go back to reference Yoo SH et al (2023) Ethical issues referred to clinical ethics support at a university hospital in Korea: three-year experience after enforcement of Life-Sustaining Treatment Decisions Act. J Korean Med Sci 38:e182CrossRefPubMedPubMedCentral Yoo SH et al (2023) Ethical issues referred to clinical ethics support at a university hospital in Korea: three-year experience after enforcement of Life-Sustaining Treatment Decisions Act. J Korean Med Sci 38:e182CrossRefPubMedPubMedCentral
9.
10.
go back to reference Strauss AL, Corbin J (1990) Basics of qualitative research: grounded theory procedures and techniques. Sage, Newbury Park, CA Strauss AL, Corbin J (1990) Basics of qualitative research: grounded theory procedures and techniques. Sage, Newbury Park, CA
11.
go back to reference Glaser BG (1978) Theoretical sensitivity: advances in the methodology of grounded theory. Sociology Press, Mill Valley, CA Glaser BG (1978) Theoretical sensitivity: advances in the methodology of grounded theory. Sociology Press, Mill Valley, CA
13.
go back to reference Mohajan D, Mohajan H (2022) Exploration of coding in qualitative data analysis: grounded theory perspective. Res Adv Educ 1:50–60CrossRef Mohajan D, Mohajan H (2022) Exploration of coding in qualitative data analysis: grounded theory perspective. Res Adv Educ 1:50–60CrossRef
14.
go back to reference Yoo SH et al (2021) Difficulties doctors experience during life-sustaining treatment discussion after enactment of the Life-Sustaining Treatment Decisions Act: a cross-sectional study. Cancer Res Treat 53:584–592CrossRefPubMed Yoo SH et al (2021) Difficulties doctors experience during life-sustaining treatment discussion after enactment of the Life-Sustaining Treatment Decisions Act: a cross-sectional study. Cancer Res Treat 53:584–592CrossRefPubMed
15.
go back to reference Gordon EJ, Daugherty CK (2003) Hitting you over the head: oncologists’ disclosure of prognosis to advanced cancer patients. Bioethics 17:142–168CrossRefPubMed Gordon EJ, Daugherty CK (2003) Hitting you over the head: oncologists’ disclosure of prognosis to advanced cancer patients. Bioethics 17:142–168CrossRefPubMed
16.
go back to reference Tanaka M, Kodama S, Lee I, Huxtable R, Chung Y (2020) Forgoing life-sustaining treatment – a comparative analysis of regulations in Japan, Korea, Taiwan, and England. BMC Med Ethics 21:99CrossRefPubMedPubMedCentral Tanaka M, Kodama S, Lee I, Huxtable R, Chung Y (2020) Forgoing life-sustaining treatment – a comparative analysis of regulations in Japan, Korea, Taiwan, and England. BMC Med Ethics 21:99CrossRefPubMedPubMedCentral
17.
go back to reference Van Keer RL, Deschepper R, Huyghens L, Bilsen J (2021) Withholding/withdrawing life-sustaining treatment in a multiethnic critical care setting: an ethnographic study. J Palliat Med 24:338–346CrossRefPubMed Van Keer RL, Deschepper R, Huyghens L, Bilsen J (2021) Withholding/withdrawing life-sustaining treatment in a multiethnic critical care setting: an ethnographic study. J Palliat Med 24:338–346CrossRefPubMed
19.
go back to reference Holloway RG et al (2014) Palliative and end-of-life care in stroke: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 45:1887–1916CrossRefPubMed Holloway RG et al (2014) Palliative and end-of-life care in stroke: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 45:1887–1916CrossRefPubMed
20.
go back to reference Lee HR, Lim C, Yun HG, Kang SH, Kim DY (2018) Making an informed decision of Korean cancer patients: the discrepancy between a patient’s recall of information and the information needed for acquisition of radiotherapy informed consent. Support Care Cancer 26:297–303CrossRefPubMed Lee HR, Lim C, Yun HG, Kang SH, Kim DY (2018) Making an informed decision of Korean cancer patients: the discrepancy between a patient’s recall of information and the information needed for acquisition of radiotherapy informed consent. Support Care Cancer 26:297–303CrossRefPubMed
Metadata
Title
Navigating shared decision-making after the Life-Sustaining Treatment Decision Act: a qualitative study of in-depth interviews with terminal cancer patients, families, and healthcare professionals
Authors
Soo-Young Yu
Yu-eun Lee
Sung Joon Shin
Go-un Woo
Dalyong Kim
Jung Hye Kwon
Do Yeun Kim
Eunyoung Eunice Suh
Publication date
01-12-2024
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 12/2024
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-024-08975-5
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Watch now